Zevalin. Novel cancer treatment shrinks tumors.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; C422802:ibritumomab tiuxetan